Canibais e Reis

  • artigos comentários

17 de Janeiro, 2010

Artigos muito recentes do Dr. Mark R. Geier explorando eventual causalidade entre exposição ao mercúrio e distúrbios neurológicos e comportamentais do espectro autista

Autor: O Primitivo. Categoria: Civilização| Saúde

Alguns artigos do Dr. Mark R. Geier acerca da exposição ao mercúrio/ timerosal e distúrbios do espectro autista (ASD). Veja a lista completa de publicações do Dr. Geier aqui. Grande parte dos seus artigos pode ser obtida em pdf aqui e/ou aqui. Como se deve imaginar, devido aos muito complexos e subtis mecanismos envolvidos, esta hipótese do mercúrio-autismo não é minimamente consensual. Em minha opinião, na dúvida e porque existem alternativas, toda a exposição ao mercúrio deve ser evitada. E isto começa por não aceitar vacinas com timerosal como é o caso desta vacina da Gripe A que está agora a ser aplicada em Portugal. É de notar que o uso desta nossa vacina não é consensual, designadamente em grávidas e crianças pois, conforme se pode ler neste artigo do Irish Times, a própria Ordem dos Médicos Alemã a desrecomendou nestes grupos específicos. Porquê? Provavelmente porque a combinação de um preservativo neurotóxico, como o timerosal/mercúrio, e do adjuvante esqualeno, o qual tem sido associado à Síndroma da Guerra do Golfo, constitui um cocktail de drogas aparentemente nunca testado a longo prazo. Neste contexto, veja-se este artigo da Natural News aqui. É compreensível que estas dúvidas levantem alguns dilemas, mas esta informação não pode deixar de ser (ou não deveria ter deixado de ser) ponderada na escolha das vacinas.

J Toxicol Environ Health A. 2009;72(24):1585-91.

A prospective blinded evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders. (pdf)

Geier DA, Kern JK, Geier MR.
Institute of Chronic Illnesses, Inc., Silver Spring, Maryland, USA.

A prospective, blinded study evaluated the relationship between autism spectrum disorder (ASD) severity measured by Childhood Autism Rating Scale (CARS) scores and urinary porphyrins among a cohort of participants (n = 26). LabCorp (CLIA-approved) tested for uroporphyrins, heptacarboxylporphyrins, hexacarboxylporphyrins, pentacarboxylporphyrins, coproporphyrin (cP) I, and cP III levels. Participants with severe ASD had significantly increased cP I, cP III, and total cP levels in comparison to participants with mild ASD. A significant correlation was observed between increasing cP levels and CARS scores. Significant correlations were also noted for comparative urinary porphyrin testing between LabCorp and the Laboratoire Philippe Auguste (ISO-approved) for total cP. Finally, total cP measured at LabCorp was found to significantly correlate with precoproporphryin (a specific porphyrin marker for mercury toxicity) measured at the Laboratoire Philippe Auguste. Since urinary porphyrin testing is clinically available, relatively inexpensive, and noninvasive, it may be used to help suggest whether heavy metal toxicity is associated with ASD.

 

Acta Neurobiol Exp (Wars). 2009;69(2):189-97.

A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity. (pdf)

Geier DA, Kern JK, Geier MR.
Institute of Chronic Illnesses, Inc., Silver Spring, Maryland, USA.

Dental amalgams containing 50% mercury (Hg) have been used in dentistry for the last 150 years, and Hg exposure during key developmental periods was associated with autism spectrum disorders (ASDs). This study examined increased Hg exposure from maternal dental amalgams during pregnancy among 100 qualifying participants born between 1990-1999 and diagnosed with DSM-IV autism (severe) or ASD (mild). Logistic regression analysis (age, gender, race, and region of residency adjusted) by quintile of maternal dental amalgams during pregnancy revealed the ratio of autism:ASD (severe:mild) were about 1 (no effect) for < or =5 amalgams and increased for > or =6 amalgams. Subjects with > or =6 amalgams were 3.2-fold significantly more likely to be diagnosed with autism (severe) in comparison to ASD (mild) than subjects with < or =5 amalgams. Dental amalgam policies should consider Hg exposure in women before and during the child-bearing age and the possibility of subsequent fetal exposure and adverse outcomes.

 

J Neurol Sci. 2009 May 15;280(1-2):101-8. Epub 2008 Sep 25.

Biomarkers of environmental toxicity and susceptibility in autism. (pdf from other journal)

Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR.
Institute of Chronic Illnesses, Inc., Silver Spring, Maryland, USA.
Comment in: J Neurol Sci. 2009 May 15;280(1-2):127-8; author reply 128-9; discussion 129-30.

Autism spectrum disorders (ASDs) may result from a combination of genetic/biochemical susceptibilities in the form of a reduced ability to excrete mercury and/or increased environmental exposure at key developmental times. Urinary porphyrins and transsulfuration metabolites in participants diagnosed with an ASD were examined. A prospective, blinded study was undertaken to evaluate a cohort of 28 participants with an ASD diagnosis for Childhood Autism Rating Scale (CARS) scores, urinary porphyrins, and transsulfuration metabolites. Testing was conducted using Vitamin Diagnostics, Inc. (CLIA-approved) and Laboratoire Philippe Auguste (ISO-approved). Participants with severe ASDs had significantly increased mercury intoxication-associated urinary porphyrins (pentacarboxyporphyrin, precoproporphyrin, and coproporphyrin) in comparison to participants with mild ASDs, whereas other urinary porphyrins were similar in both groups. Significantly decreased plasma levels of reduced glutathione (GSH), cysteine, and sulfate were observed among study participants relative to controls. In contrast, study participants had significantly increased plasma oxidized glutathione (GSSG) relative to controls. Mercury intoxication-associated urinary porphyrins were significantly correlated with increasing CARS scores and GSSG levels, whereas other urinary porphyrins did not show these relationships. The urinary porphyrin and CARS score correlations observed among study participants suggest that mercury intoxication is significantly associated with autistic symptoms. The transsulfuration abnormalities observed among study participants indicate that mercury intoxication was associated with increased oxidative stress and decreased detoxification capacity.

 

Toxicological & Environmental Chemistry, Volume 91, Issue 4 June 2009, pages 735-749

Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to thimerosal and other metal compounds (pdf)

D. A. Geier; P. G. King; M. R. Geier.
Institute of Chronic Illnesses, Inc., Maryland, USA; CoMeD, Inc., Maryland, USA; The Genetic Centers of America, Maryland, USA

Thimerosal (ethylmercurithiosalicylic acid), an ethylmercury (EtHg)-releasing compound (49.55% mercury (Hg)), was used in a range of medical products for more than 70 years. Of particular recent concern, routine administering of Thimerosal-containing biologics/childhood vaccines have become significant sources of Hg exposure for some fetuses/infants. This study was undertaken to investigate cellular damage among in vitro human neuronal (SH-SY-5Y neuroblastoma and 1321N1 astrocytoma) and fetal (nontransformed) model systems using cell vitality assays and microscope-based digital image capture techniques to assess potential damage induced by Thimerosal and other metal compounds (aluminum (Al) sulfate, lead (Pb)(II) acetate, methylmercury (MeHg) hydroxide, and mercury (Hg)(II) chloride) where the cation was reported to exert adverse effects on developing cells. Thimerosal-associated cellular damage was also evaluated for similarity to pathophysiological findings observed in patients diagnosed with autistic disorders (ADs). Thimerosal-induced cellular damage as evidenced by concentration- and time-dependent mitochondrial damage, reduced oxidative-reduction activity, cellular degeneration, and cell death in the in vitro human neuronal and fetal model systems studied. Thimerosal at low nanomolar (nM) concentrations induced significant cellular toxicity in human neuronal and fetal cells. Thimerosal-induced cytoxicity is similar to that observed in AD pathophysiologic studies. Thimerosal was found to be significantly more toxic than the other metal compounds examined. Future studies need to be conducted to evaluate additional mechanisms underlying Thimerosal-induced cellular damage and assess potential co-exposures to other compounds that may increase or decrease Thimerosal-mediated toxicity.

 

Indian J Med Res. 2008 Oct;128(4):383-411.

A comprehensive review of mercury provoked autism. (pdf)

Geier DA, King PG, Sykes LK, Geier MR.
The Institute of Chronic Illnesses, Silver Spring, MD, USA.

Emerging evidence supports the theory that some autism spectrum disorders (ASDs) may result from a combination of genetic/biochemical susceptibility, specifically a reduced ability to excrete mercury (Hg), and exposure to Hg at critical developmental periods. Elemental/inorganic Hg is released into the air/water where it becomes methylated and accumulates in animal tissues. The US population is primarily exposed to methyl-Hg by fish consumption. In addition, many pharmaceuticals have been, and some continue to be, a ubiquitous source of danger because they contain mercurials. Mercurials may be found in drugs for the eye, ear, nose, throat, and skin; in bleaching creams; as preservatives in cosmetics, tooth pastes, lens solutions, vaccines, allergy test and immunotherapy solutions; in antiseptics, disinfectants, and contraceptives; in fungicides and herbicides; in dental fillings and thermometers; and many other products. Hg has been found to cause immune, sensory, neurological, motor, and behavioural dysfunctions similar to traits defining/associated with ASDs, and that these similarities extend to neuroanatomy, neurotransmitters, and biochemistry. Furthermore, a review of molecular mechanisms indicates that Hg exposure can induce death, disorganization and/or damage to selected neurons in the brain similar to that seen in recent ASD brain pathology studies, and this alteration may likely produce the symptoms by which ASDs are diagnosed. Finally, a review of treatments suggests that ASD patients who undergo protocols to reduce Hg and/or its effects show significant clinical improvements in some cases. In conclusion, the overwhelming preponderance of the evidence favours acceptance that Hg exposure is capable of causing some ASDs.

 

Expert Rev Mol Diagn. 2008 Nov;8(6):671-4.

Autism spectrum disorder-associated biomarkers for case evaluation and management by clinical geneticists. (pdf)

Geier DA, Geier MR.

 

Indian J Med Res. 2008 Oct;128(4):383-411.

A comprehensive review of mercury provoked autism. (pdf)

Geier DA, King PG, Sykes LK, Geier MR.
The Institute of Chronic Illnesses, Silver Spring, MD, USA.

Emerging evidence supports the theory that some autism spectrum disorders (ASDs) may result from a combination of genetic/biochemical susceptibility, specifically a reduced ability to excrete mercury (Hg), and exposure to Hg at critical developmental periods. Elemental/inorganic Hg is released into the air/water where it becomes methylated and accumulates in animal tissues. The US population is primarily exposed to methyl-Hg by fish consumption. In addition, many pharmaceuticals have been, and some continue to be, a ubiquitous source of danger because they contain mercurials. Mercurials may be found in drugs for the eye, ear, nose, throat, and skin; in bleaching creams; as preservatives in cosmetics, tooth pastes, lens solutions, vaccines, allergy test and immunotherapy solutions; in antiseptics, disinfectants, and contraceptives; in fungicides and herbicides; in dental fillings and thermometers; and many other products. Hg has been found to cause immune, sensory, neurological, motor, and behavioural dysfunctions similar to traits defining/associated with ASDs, and that these similarities extend to neuroanatomy, neurotransmitters, and biochemistry. Furthermore, a review of molecular mechanisms indicates that Hg exposure can induce death, disorganization and/or damage to selected neurons in the brain similar to that seen in recent ASD brain pathology studies, and this alteration may likely produce the symptoms by which ASDs are diagnosed. Finally, a review of treatments suggests that ASD patients who undergo protocols to reduce Hg and/or its effects show significant clinical improvements in some cases. In conclusion, the overwhelming preponderance of the evidence favours acceptance that Hg exposure is capable of causing some ASDs.

 

Expert Rev Mol Diagn. 2008 Nov;8(6):671-4.

Autism spectrum disorder-associated biomarkers for case evaluation and management by clinical geneticists. (pdf)

Geier DA, Geier MR.

 

J Neurol Sci. 2008 Aug 15;271(1-2):110-8. Epub 2008 May 15.

Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. (pdf)

Young HA, Geier DA, Geier MR.
The George Washington University School of Public Health and Health Services, Department of Epidemiology and Biostatistics, United States.

The study evaluated possible associations between neurodevelopmental disorders (NDs) and exposure to mercury (Hg) from Thimerosal-containing vaccines (TCVs) by examining the automated Vaccine Safety Datalink (VSD). A total of 278,624 subjects were identified in birth cohorts from 1990-1996 that had received their first oral polio vaccination by 3 months of age in the VSD. The birth cohort prevalence rate of medically diagnosed International Classification of Disease, 9th revision (ICD-9) specific NDs and control outcomes were calculated. Exposures to Hg from TCVs were calculated by birth cohort for specific exposure windows from birth-7 months and birth-13 months of age. Poisson regression analysis was used to model the association between the prevalence of outcomes and Hg doses from TCVs. Consistent significantly increased rate ratios were observed for autism, autism spectrum disorders, tics, attention deficit disorder, and emotional disturbances with Hg exposure from TCVs. By contrast, none of the control outcomes had significantly increased rate ratios with Hg exposure from TCVs. Routine childhood vaccination should be continued to help reduce the morbidity and mortality associated with infectious diseases, but efforts should be undertaken to remove Hg from vaccines. Additional studies should be conducted to further evaluate the relationship between Hg exposure and NDs.

 

J Toxicol Environ Health B Crit Rev. 2007 Dec;10(8):575-96.

A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. (pdf)

Geier DA, Sykes LK, Geier MR.
The Institute of Chronic Illnesses, Inc., Silver Spring, Maryland, USA.

Thimerosal (Merthiolate) is an ethylmercury-containing pharmaceutical compound that is 49.55% mercury and that was developed in 1927. Thimerosal has been marketed as an antimicrobial agent in a range of products, including topical antiseptic solutions and antiseptic ointments for treating cuts, nasal sprays, eye solutions, vaginal spermicides, diaper rash treatments, and perhaps most importantly as a preservative in vaccines and other injectable biological products, including Rho(D)-immune globulin preparations, despite evidence, dating to the early 1930s, indicating Thimerosal to be potentially hazardous to humans and ineffective as an antimicrobial agent. Despite this, Thimerosal was not scrutinized as part of U.S. pharmaceutical products until the 1980s, when the U.S. Food and Drug Administration finally recognized its demonstrated ineffectiveness and toxicity in topical pharmaceutical products, and began to eliminate it from these. Ironically, while Thimerosal was being eliminated from topicals, it was becoming more and more ubiquitous in the recommended immunization schedule for infants and pregnant women. Furthermore, Thimerosal continues to be administered, as part of mandated immunizations and other pharmaceutical products, in the United States and globally. The ubiquitous and largely unchecked place of Thimerosal in pharmaceuticals, therefore, represents a medical crisis.

 

J Toxicol Environ Health A. 2007 Oct;70(20):1723-30.

A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. (pdf)

Geier DA, Geier MR.
Institute of Chronic Illnesses, Silver Spring, Maryland, USA.

Porphyrins are derivatives formed in the heme synthesis pathway and porphyrins afford a measure of xenobiotic exposure. The steps in the heme pathway most vulnerable to heavy metal inhibition are uroporphyrin decarboxylase (UROD) and coproporphyrinogen oxidase (CPOX) reactions. Mercury toxicity was associated with elevations in urinary coproporphyrin (cP), pentacarboxyporphyrin (5cxP), and precoproporphyrin (prcP) (also known as keto-isocoproporphyrin) levels. Two cohorts of autistic patients in the United States and France had urine porphyrin levels associated with mercury toxicity. A prospective study of urinary porphyrin testing at LabCorp (United States) and the Laboratoire Philippe Auguste (France) involving 71 autism spectrum disorder (ASD) patients, neurotypical sibling controls, and general population controls was undertaken. ASD patients had significant elevations in urinary levels of cP, 5cxP, and prcP relative to controls, and > 50% of ASD patients had urinary cP levels more than 2 standard deviations above the mean values for neurotypical sibling controls. Significant reductions in urinary 5cxP and cP levels were observed in ASD patients following chelation. A significant correlation was found between urinary porphyrins measured at LabCorp and those measured at the Laboratoire Philippe Auguste on individual ASD patients. The established developmental neurotoxicity attributed to mercury and biochemical/genomic evidence for mercury susceptibility/toxicity in ASDs indicates a causal role for mercury. Urinary porphyrin testing is clinically available, relatively inexpensive, and noninvasive. Porphyrins need to be routinely measured in ASDs to establish if mercury toxicity is a causative factor and to evaluate the effectiveness of chelation therapy.

 

J Toxicol Environ Health A. 2007 May 15;70(10):837-51.

A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders. (pdf)

Geier DA, Geier MR.
Institute of Chronic Illnesses, Inc., Silver Spring, Maryland, USA.

Impairments in social relatedness and communication, repetitive behaviors, and stereotypic abnormal movement patterns characterize autism spectrum disorders (ASDs). It is clear that while genetic factors are important to the pathogenesis of ASDs, mercury exposure can induce immune, sensory, neurological, motor, and behavioral dysfunctions similar to traits defining or associated with ASDs. The Institutional Review Board of the Institute for Chronic Illnesses (Office for Human Research Protections, U.S. Department of Health and Human Services, IRB number IRB00005375) approved the present study. A case series of nine patients who presented to the Genetic Centers of America for a genetic/developmental evaluation are discussed. Eight of nine patients (one patient was found to have an ASD due to Rett’s syndrome) (a) had regressive ASDs; (b) had elevated levels of androgens; (c) excreted significant amounts of mercury post chelation challenge; (d) had biochemical evidence of decreased function in their glutathione pathways; (e) had no known significant mercury exposure except from Thimerosal-containing vaccines/Rho(D)-immune globulin preparations; and (f) had alternate causes for their regressive ASDs ruled out. There was a significant dose-response relationship between the severity of the regressive ASDs observed and the total mercury dose children received from Thimerosal-containing vaccines/Rho (D)-immune globulin preparations. Based upon differential diagnoses, 8 of 9 patients examined were exposed to significant mercury from Thimerosal-containing biologic/vaccine preparations during their fetal/infant developmental periods, and subsequently, between 12 and 24 mo of age, these previously normally developing children suffered mercury toxic encephalopathies that manifested with clinical symptoms consistent with regressive ASDs. Evidence for mercury intoxication should be considered in the differential diagnosis as contributing to some regressive ASDs.

 

Neuro Endocrinol Lett. 2006 Aug;27(4):401-13.

A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. (pdf)

Geier DA, Geier MR.
The Institute for Chronic Illnesses, Inc., Silver Spring, MD 20905, USA.

BACKGROUND: Thimerosal is an ethylmercury-containing compound (49.6% mercury by weight) used as at the preservative level in vaccines (0.005% to 0.01%). METHODS: Statistical modeling in a meta-analysis epidemiological assessment of the Vaccine Adverse Event Reporting System (VAERS) for neurodevelopment disorders (NDs) reported following Diphtheria-Tetanus-whole-cell-Pertussis (DTP) vaccines in comparison to Diphtheria-Tetanus-whole-cell-Pertussis-Haemophilus Influenzae Type b (DTPH) vaccines (administered: 1994-1997) and following Thimerosal-containing Diphtheria-Tetanus-acellular-Pertussis (DTaP), vaccines in comparison to Thimerosal-free DTaP vaccines (administered: 1997-2000), was undertaken. RESULTS: Significantly increased adjusted (sex, age, vaccine type, vaccine manufacturer) risks of autism, speech disorders, mental retardation, personality disorders, thinking abnormalities, ataxia, and NDs in general, with minimal systematic error or confounding, were associated with TCV exposure. CONCLUSION: It is clear from the results of the present epidemiological study and other recently published data associating mercury exposure with childhood NDs, additional ND research should be undertaken in the context of evaluating mercury-associated exposures, especially from Thimerosal-containing vaccines.

 

J Toxicol Environ Health A. 2006 Aug;69(15):1481-95.

An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States. (pdf)

Geier DA, Geier MR.
The Genetic Centers of America, Silver Spring, Maryland 20905, USA.

Thimerosal is an ethylmercury (49.55% mercury by weight) preservative historically added to some vaccines. Toxicokinetic studies showed children in the United States received doses of mercury from Thimerosal-containing vaccines (TCVs) in excess of safety guidelines. In the United States during the 1990s, diphtheria-tetanus-pertussis (DTP) and Haemophilus influenzae type b (Hib) vaccines (maximally, 50 mug mercury per joint administration) and diphtheria-tetanus-pertussis-Haemophilus influenzae type b (DTPH) vaccines (25 mug mercury per administration) were given to children in the same childhood vaccination schedule at 2, 4, 6, and 15-18 mo, so that children receiving DTP and Hib vaccines may have maximally received an additional 100 mug more mercury exposure from TCVs than children administered DTPH vaccines. A case-control epidemiological study of neurodevelopmental disorders (NDs) reported to the Vaccine Adverse Event Reporting System (VAERS) (online public access version; updated 31 August 2004) following administration of DTP vaccines in comparison DTPH vaccines manufactured by Lederle Laboratories (Pearl River, NY) from 1994 through 1998 was undertaken. Significantly increased odds ratios for autism, speech disorders, mental retardation, infantile spasms, and thinking abnormalities reported to VAERS were found following DTP vaccines in comparison to DTPH vaccines with minimal bias or systematic error. Additional ND research should be undertaken in the context of evaluating mercury-associated exposures, especially since in 2005 the Institute of Medicine issued a report calling into question handling of vaccine safety data by the National Immunization Program of the Centers for Disease Control and Prevention.

 

Med Sci Monit. 2006 Jun;12(6):CR231-9. Epub 2006 May 29.

An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines. (pdf)

Geier DA, Geier MR.
Department of Biochemistry, George Washington University, Washington, DC, USA.

BACKGROUND: The US is in the midst of an epidemic of neurodevelopmental disorders (NDs). Thimerosal is an ethylmercury-containing compound added to some childhood vaccines. Several previous epidemiological studies conducted in the US have associated Thimerosal-containing vaccine (TCV) administration with NDs. MATERIAL/METHODS: An ecological study was undertaken to evaluate NDs reported to the Vaccine Adverse Event Reporting System (VAERS) from 1991 through 2004 by date of receipt and by date of vaccine administration. The NDs examined included autism, mental retardation, and speech disorders. Statistical trend analysis was employed to evaluate the effects of removal of Thimerosal on the proportion of NDs reported to VAERS. RESULTS: There was a peak in the proportion of ND reports received by VAERS in 2001-2002 and in the proportion of ND reports by date of vaccine administration in 1998. There were significant reductions in the proportion of NDs reported to VAERS as Thimerosal was begun to be removed from childhood vaccines in the US from mid-1999 onwards. CONCLUSIONS: The present study provides the first epidemiological evidence showing that as Thimerosal was removed from childhood vaccines, the number of NDs has decreased in the US. The analysis techniques utilized attempted to minimize chance or bias/confounding. Additional research should be conducted to further evaluate the relationship between TCVs and NDs. This is especially true because the handling of vaccine safety data from the National Immunization Program of the CDC has been called into question by the Institute of Medicine of the National Academy of Sciences in 2005.

 

Med Sci Monit. 2005 Apr;11(4):CR160-70. Epub 2005 Mar 24.

A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis. (pdf)

Geier DA, Geier MR. MedCon, Inc., USA.

BACKGROUND: Thimerosal is an ethylmercury-containing preservative in vaccines. Toxicokinetic studies have shown children received doses of mercury from thimerosal-containing vaccines (TCVs) that were in excess of safety guidelines. Previously, an ecological study showing a significant association between TCVs and neurodevelopmental disorders (NDs) in the US was published in this journal. MATERIAL/METHODS: A two phased population-based epidemiological study was undertaken. Phase one evaluated reported NDs to the Vaccine Adverse Event Reporting System (VAERS) following thimerosal-containing Diphtheria-Tetanus-acellular-Pertussis (DTaP) vaccines in comparison to thimerosal-free DTaP vaccines administered from 1997 through 2001. Phase two evaluated the automated Vaccine Safety Datalink (VSD) for cumulative exposures to mercury from TCVs at 1-, 2-, 3-, and 6-months-of-age for infants born from 1992 through 1997 and the eventual risk of developing NDs. RESULTS: Phase one showed significantly increased risks for autism, speech disorders, mental retardation, personality disorders, and thinking abnormalities reported to VAERS following thimerosal-containing DTaP vaccines in comparison to thimerosal-free DTaP vaccines. Phase two showed significant associations between cumulative exposures to thimerosal and the following types of NDs: unspecified developmental delay, tics, attention deficit disorder (ADD), language delay, speech delay, and neurodevelopmental delays in general. CONCLUSIONS: This study showed that exposure to mercury from TCVs administered in the US was a consistent significant risk factor for the development of NDs. It is clear from these data and other recent publications linking TCVs with NDs that additional ND research should be undertaken in the context of evaluating mercury-associated exposures and thimerosal-free vaccines should be made available.

 

Med Hypotheses. 2005;64(5):946-54.

The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. (pdf)

Geier MR, Geier DA.
The Genetic Centers of America, 14 Redgate Ct., Silver Spring, MD 20905, USA.

Autism is a neurodevelopmental disorder that according to the Centers for Disease Control and Prevention (CDC) affects 1 in 150 children in the United States. Autism is characterized by impairments in social relatedness and communication, repetitive behaviors, abnormal movements, and sensory dysfunction. Recently emerging evidence suggests that mercury, especially from childhood vaccines, appears to be a factor in the development of the autistic disorders, and that autistic children have higher than normal body-burdens of mercury. In considering mercury toxicity, it has previously been shown that testosterone significantly potentates mercury toxicity, whereas estrogen is protective. Examination of autistic children has shown that the severity of autistic disorders correlates with the amount of testosterone present in the amniotic fluid, and an examination of a case-series of autistic children has shown that some have plasma testosterone levels that were significantly elevated in comparison neurotypical control children. A review of some of the current biomedical therapies for autistics, such as glutathione and cysteine, chelation, secretin, and growth hormone, suggests that they may in fact lower testosterone levels. We put forward the medical hypothesis that autistic disorders, in fact, represents a form of testosterone mercury toxicity, and based upon this observation, one can design novel treatments for autistics directed towards higher testosterone levels in autistic children. We suggest a series of experiments that need to be conducted in order to evaluate the exact mechanisms for mercury-testosterone toxicity, and various types of clinical manipulations that may be employed to control testosterone levels. It is hoped by devising therapies that address the steroid hormone pathways, in addition to the current treatments that successful lower heavy metal body-burdens of mercury, will work synergistically to improve clinical outcomes. In light of the fact that there are a number of other diseases that may have a chronic mercury toxicity component, such as Alzheimer’s disease, heart disease, obesity, ALS, asthma, and other various forms of autoimmune disorders, it is imperative that further research should be conducted to understand mercury-testosterone toxicity.

 

Int J Toxicol. 2004 Nov-Dec;23(6):369-76.

Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis. (pdf)

Geier D, Geier MR.
MedCon, Inc., Maryland, USA.

The authors previously published the first epidemiological study from the United States associating thimerosal from childhood vaccines with neurodevelopmental disorders (NDs) based upon assessment of the Vaccine Adverse Event Reporting System (VAERS). A number of years have gone by since their previous analysis of the VAERS. The present study was undertaken to determine whether the previously observed effect between thimerosal-containing childhood vaccines and NDs are still apparent in the VAERS as children have had a chance to further mature and potentially be diagnosed with additional NDs. In the present study, a cohort of children receiving thimerosal-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines in comparison to a cohort of children receiving thimerosal-free DTaP vaccines administered from 1997 through 2000 based upon an assessment of adverse events reported to the VAERS were evaluated. It was determined that there were significantly increased odds ratios (ORs) for autism (OR = 1.8, p < .05), mental retardation (OR = 2.6, p < .002), speech disorder (OR = 2.1, p < .02), personality disorders (OR = 2.6, p < .01), and thinking abnormality (OR = 8.2, p < .01) adverse events reported to the VAERS following thimerosal-containing DTaP vaccines in comparison to thimerosal-free DTaP vaccines. Potential confounders and reporting biases were found to be minimal in this assessment of the VAERS. It was observed, even though the media has reported a potential association between autism and thimerosal exposure, that the other NDs analyzed in this assessment of the VAERS had significantly higher ORs than autism following thimerosal-containing DTaP vaccines in comparison to thimerosal-free DTaP vaccines. The present study provides additional epidemiological evidence supporting previous epidemiological, clinical and experimental evidence that administration of thimerosal-containing vaccines in the United States resulted in a significant number of children developing NDs.

 

Med Sci Monit. 2004 Mar;10(3):PI33-9. Epub 2004 Mar 1.

A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. (pdf)

Geier DA, Geier MR. President, MedCon, Inc, Silver Spring, MD, USA.
Comment in: Med Sci Monit. 2005 Oct;11(10):LE13-4.

BACKGROUND: The purpose of the study was to evaluate the effects of MMR immunization and mercury from thimerosal-containing childhood vaccines on the prevalence of autism. MATERIAL/METHODS: Evaluations of the Biological Surveillance Summaries of the Centers for Disease Control and Prevention (CDC), the U.S. Department of Education datasets, and the CDC’s yearly live birth estimates were undertaken RESULTS: It was determined that there was a close correlation between mercury doses from thimerosal–containing childhood vaccines and the prevalence of autism from the late 1980s through the mid-1990s. In contrast, there was a potential correlation between the number of primary pediatric measles-containing vaccines administered and the prevalence of autism during the 1980s. In addition, it was found that there were statistically significant odds ratios for the development of autism following increasing doses of mercury from thimerosal-containing vaccines (birth cohorts: 1985 and 1990-1995) in comparison to a baseline measurement (birth cohort: 1984). The contribution of thimerosal from childhood vaccines (>50% effect) was greater than MMR vaccine on the prevalence of autism observed in this study. CONCLUSIONS: The results of this study agree with a number of previously published studies. These studies have shown that there is biological plausibility and epidemiological evidence showing a direct relationship between increasing doses of mercury from thimerosal-containing vaccines and neurodevelopmental disorders, and measles-containing vaccines and serious neurological disorders. It is recommended that thimerosal be removed from all vaccines, and additional research be undertaken to produce a MMR vaccine with an improved safety profile.

 

Pediatr Rehabil. 2003 Apr-Jun;6(2):97-102.

An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. (pdf)

Geier DA, Geier MR.
The Genetic Centers of America, 14 Redgate Court, Silver Spring, MD 20905, USA.

The prevalence of autism in the US has risen from 1 in approximately 2500 in the mid-1980s to 1 in approximately 300 children in the mid-1990s. The purpose of this study was to evaluate whether mercury from thimerosal in childhood vaccines contributed to neurodevelopmental disorders. Neurodevelopmental disorder dose-response curves for increasing mercury doses of thimerosal in childhood vaccines were determined based upon examination of the Vaccine Adverse Events Reporting System (VAERS) database and the 2001 US’ Department of Education Report. The instantaneous dosage of mercury children received in comparison to the Food and Drug Administration (FDA)’s maximum permissible dose for the oral ingestion of methylmercury was also determined. The dose-response curves showed increases in odds ratios of neurodevelopmental disorders from both the VAERS and US Department of Education data closely linearly correlated with increasing doses of mercury from thimerosal-containing childhood vaccines and that for overall odds ratios statistical significance was achieved. Similar slopes and linear regression coefficients for autism odds ratios in VAERS and the US Department of Education data help to mutually validate each other. Controls employed in the VAERS and US Department of Education data showed minimal biases. The evidence presented here shows that the occurrence of neurodevelopmental disorders following thimerosal-containing childhood vaccines does not appear to be coincidental.

 

Exp Biol Med (Maywood). 2003 Jun;228(6):660-4.

Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. (pdf)

Geier MR, Geier DA.
The Genetic Centers of America, Silver Spring, Maryland 20905, USA.
Comment in: 
Exp Biol Med (Maywood). 2003 Oct;228(9):991-2; discussion 993-4.

We were initially highly skeptical that differences in the concentrations of thimerosal in vaccines would have any effect on the incidence rate of neurodevelopmental disorders after childhood immunization. This study presents the first epidemiologic evidence, based upon tens of millions of doses of vaccine administered in the United States, that associates increasing thimerosal from vaccines with neurodevelopmental disorders. Specifically, an analysis of the Vaccine Adverse Events Reporting System (VAERS) database showed statistical increases in the incidence rate of autism (relative risk [RR] = 6.0), mental retardation (RR = 6.1), and speech disorders (RR = 2.2) after thimerosal-containing diphtheria, tetanus, and acellular pertussis (DTaP) vaccines in comparison with thimerosal-free DTaP vaccines. The male/female ratio indicated that autism (17) and speech disorders (2.3) were reported more in males than females after thimerosal-containing DTaP vaccines, whereas mental retardation (1.2) was more evenly reported among male and female vaccine recipients. Controls were employed to determine if biases were present in the data, but none were found. It was determined that overall adverse reactions were reported in similar-aged populations after thimerosal-containing DTaP (2.4 +/- 3.2 years old) and thimerosal-free DTaP (2.1 +/- 2.8 years old) vaccinations. Acute control adverse reactions such as deaths (RR = 1.0), vasculitis (RR = 1.2), seizures (RR = 1.6), ED visits (RR = 1.4), total adverse reactions (RR = 1.4), and gastroenteritis (RR = 1.1) were reported similarly after thimerosal-containing and thimerosal-free DTaP vaccines. An association between neurodevelopmental disorders and thimerosal-containing DTaP vaccines was found, but additional studies should be conducted to confirm and extend this study.

 



Tags: asd, autismo, Dr. Mark R. Geier, mercúrio, Timerosal

sem comentários a este artigo.

Formulário para comentário

Categorias

Eventos

Sondagem

Loading ... Loading ...

RSS Primal Wisdom (Don Matez)

  • Practically Paleo Diet Reduces Markers of Aging In Humans
  • Practically Paleo Perspective: Rice
  • My Meals 4/16/10
  • Paleo Strength Works For Women Too; and Paleo Kits
  • Practically Paleo: My Meals
  • Paleo Basics: How Much Sugar in Wild Fruits?
  • Paleo Basics: Fructose Fact Vs. Fiction
  • Paleo Diet Analysis: Kitavan Analogue Diet
  • Paleo Diet pH: Does It Matter, part VII
  • Practically Paleo Diet Supplementation: How Much Vitamin D?

Medicina (notícias)

National Survey Shows 95% Of Women Do Not Know Their Breast Density Despite Increased Cancer Risk
Toxcure's Neurotoxin Treatment For Cancer Gains U.S. Patent
New path for novel Alzheimer's therapies
Invention regulates nerve cells electronically
Large number of public wells in U.S. have potentially harmful contaminants in source water, study finds
To publish or not to publish? That is the question
Uncovering lithium's mode of action
Systems biology helps explain hematopoiesis
Better way to detect food allergies
Scientists make important step toward stopping plaque-like formations in Huntington's disease
Silica cages help anti-cancer antibodies kill tumors in mice
Intracellular express: Why transport protein molecules have brakes
Encouraging Data Presented On Oncophage(R) Vaccine At International Conference On Brain Tumor Research And Therapy
Cardiovascular Devices From Medtronic Featured Prominently At EuroPCR
Orthofix International Launches Three New Sports Medicine Products
Presence of chemical in smoker's breath indicates person has smoked in last three days
Wellstat Investigational Drug Shows Life-Saving Potential In Treating Toxicity Of Widely Used Cancer Chemotherapy
Heart attack survivors 'fear sex'
Do Special Diets Ease Symptoms of RA?
Food Allergies: 5 Myths Debunked
Depression Affects Kids as Young as 3
Hepatitis C: Silent Disease Affects 4 Million Americans
Rocking Eases Postop Ileus (CME/CE)
ZymoGenetics Announces Upcoming Presentation Of Positive IL-21 Phase 2 Results In Metastatic Melanoma At ASCO Meeting
Yoga Helped Cancer Survivors Reduce Fatigue, Improve Sleep Quality

Nacional (notícias)

Secretário de Estado Adjunto na contratualização dos ACES do Alentejo
Dia Mundial da Esclerose Múltipla
A III Gala da Ciência é já amanhã!
Ministra nomeia administração do Hospital Garcia de Orta
Newsletter do Portal da Saúde - 21 de Maio 2010
1.º Curso Teórico-Prático de Voz
SeM Violência Familiar
1.º Curso teórico-prático de voz
Está a proteger bem a sua pele?
Workshop sobre ética: «Ainda precisamos de células estaminais embrionárias humanas?»
«Noite de Solidariedade» no Dia Mundial da Esclerose Múltipla
I Congresso Internacional da Saúde Gaia-Porto
Atribuição de subsídios a pessoas colectivas privadas
Frutas ricas em vitamina C
Cosméticos na gravidez
Respiração completa
O que sabe sobre antioxidantes?
IIII Jornadas de Endocrinologia Diabetes e Nutrição e II Simpósio de Nutrição
6.º Dia Nacional da Luta contra a Obesidade e 1.º Dia Europeu da Obesidade
Azambuja efectua de 24 de Maio até 9 de Setembro rastreio do cancro da mama
Rejuvenesça durante a noite
III Jornadas de Endocrinologia Diabetes e Nutrição e o II Simpósio de Nutrição
6.º Dia Nacional da Luta contra a Obesidade e 1.º Dia Europeu da Obesidade
Dia 26 de Maio a Associação Portuguesa de Cancro Cutâneo assinala o Euromelanoma 2010
2º EMG - Encontro Multidisciplinar Graduado - Endocrinologia, Gastrenterologia e Reumatologia

  • Alexandre: Meu caro Ricardo, como sempre os teus temas são fabulosos. Há algum tempo que me interesso pelo jejum intermitente, principalmente devido a alguns e
  • J.P.: Great videos! I especially enjoyed seeing the results in the 3rd video. Lots of good links in this post as well. I also have some
  • Cristiane: Então, Sou vegana há pouco tempo, vegetariana há 8 anos. Fui grávida vegana, meu filho é vegano, meu marido também. Nós continuamos existindo

Álbum fotográfico

paleodieta3_141007paleodieta_101007paleodieta_070508paleodieta1_050708

Canibais e Reis

"As populações da Idade da Pedra tinham vidas mais saudáveis do que a maior parte do povo que surgiu imediatamente depois delas. Quanto a facilidades, como a boa alimentação, os divertimentos e os prazeres estéticos, os primitivos caçadores e recolectores de plantas gozavam de luxos que só os mais ricos dos nossos dias podem gozar" - Marvin Harris (1927-2001).

Twitter list

Dietas primitivas e tradicionais

Civilização

Hipótese Lipídica

Lípidos

Perfil lipídico

Vitamina D

Corrida

Podcasts (áudio)